Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:09 AM
Ignite Modification Date:
2025-12-25 @ 12:09 AM
NCT ID:
NCT00329758
Eligibility Criteria:
Inclusion Criteria:
* Man or woman \>16 and \<50 years with HI less 24 hours in progression and Glasgow between 9 y 12.
* Man or woman \>16 and \<50 years with HI and Glasgow l3, with lesions in TC scan.
* Acceptance of family to participate (first grade).
Exclusion Criteria:
* History of HI with disability
* History of neurological or psychiatric disease with disability.
* Administration 24 hrs previous of: fibrates, niacin, ciclosporin, azoles, macrolides, inhibitors of protease, nefazodone, verapamil, diltiazem,amiodarone.
* Existence of systemic injury with life in compromise (massive bleeding, exposition of bone in fracture, hepatic or splenic laceration or in great vessels and shock).
* Administration of THAM, mannitol, barbiturates, corticosteroids, scavengers of free radicals, inhibitors of lipidic peroxidation, indometacin, calcium antagonist, antagonists of neurotransmitters
* Existence of intracranial lesion which needs surgery.
* Lesions not classifiable or in brainstem.
* Allergy to the drug.
* Hepatopathy or myopathy (or) history of this, or clinical data of hepatic disease.
* Management previous in other Hospital.
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Maximum Age:
50 Years
Study:
NCT00329758
Study Brief:
Protocol Section:
NCT00329758